Article
Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants.
EBioMedicine - 1 Dec 2021
Wu Qiong, Li Jiankang, Sun Xiaohui, He Di, Cheng Zongxue, Li Jun, Zhang Xuhui, Xie Yongming, Zhu Yimin, Lai Maode
Abstract excerpt
BACKGROUND: Metabolic syndrome (MetS) is a cluster of multiple cardiometabolic risk factors that increase the risk of type 2 diabetes and cardiovascular diseases. Identifying novel biomarkers of MetS and their genetic associations could provide insights into the mechanisms of cardiometabolic diseases. METHODS: Potential MetS-associated metabolites were screened and internally validated by untargeted metabolomics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
